SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:uu-101003"
 

Sökning: id:"swepub:oai:DiVA.org:uu-101003" > Minimal residual di...

Minimal residual disease assessment in childhood acute lymphoblastic leukemia : Results of a Swedish multi-centre study comparing real-time PCR and multi-colour flow cytometry

Thörn, Ingrid, 1957- (författare)
Uppsala universitet,Hematologi och immunologi,Molecular Hematology
Forestier, Erik (författare)
Department of Clinical Sciences, Paediatrics, Umeå University, Umeå, Sweden
Botling, Johan (författare)
Uppsala universitet,Hematologi och immunologi,Molecular Hematology
visa fler...
Thuresson, Britt (författare)
Division of Hematology & Transfusion Medicine, Department of Laboratory Medicine, Lund University, Lund, Sweden
Wasslavik, Carina (författare)
Department of Clinical Chemistry and Transfusion Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
Björklund, Elisabeth (författare)
Department of Pathology, Karolinska University Hospital, Stockholm, Sweden
Aihong, Li (författare)
Department of Biosciences, Clinical Chemistry, Umeå University, Umeå, Sweden
Lindström-Eriksson, Elenor (författare)
Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden
Grönlund, Elisabet (författare)
Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden
Torikka, Kerstin (författare)
Division of Hematology & Transfusion Medicine, Department of Laboratory Medicine, Lund University, Lund, Sweden
Heldrup, Jesper (författare)
Department of Pediatrics, Lund University Hospital, Lund, Sweden
Abrahamsson, Jonas (författare)
Queen Silvias Children’s Hospital, Gothenburg, Sweden
Behrendtz, Mikael (författare)
Department of Pediatrics, University Hospital, Linköping, Sweden
Söderhäll, Stefan (författare)
Department of Pediatric Oncology, Karolinska University Hospital, Stockholm, Sweden
Jacobsson, Stefan (författare)
Department of Clinical Chemistry and Transfusion Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
Roos, Göran (författare)
Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden
Olofsson, Tor (författare)
Division of Hematology & Transfusion Medicine, Department of Laboratory Medicine, Lund University, Lund, Sweden
Porwit, Anna (författare)
Department of Pathology, Karolinska University Hospital, Stockholm, Sweden
Lönnerholm, Gudmar (författare)
Uppsala universitet,Institutionen för kvinnors och barns hälsa
Rosenquist, Richard (författare)
Uppsala universitet,Hematologi och immunologi,Molecular Hematology
Sundström, Christer (författare)
Uppsala universitet,Hematologi och immunologi,Molecular Hematology
visa färre...
 (creator_code:org_t)
2009
Engelska.
  • Annan publikation (övrigt vetenskapligt/konstnärligt)
Abstract Ämnesord
Stäng  
  • In this Swedish multi-center study of early treatment response in childhood acute lymphoblastic leukemia (ALL), we evaluated the concordance between multicolour flow cytometry (FCM) and real-time quantitative polymerase chain reaction (RQ-PCR) for assessment of minimal residual disease (MRD). Multiple time points (i.e. day 15, 29, 50 and 106) were evaluated with the NOPHO (Nordic Society of Pediatric Hematology and Oncology) ALL 2000 treatment protocol as backbone. During 2002-2006, 334 children were diagnosed with ALL, where 228 had paired samples taken at any of the four time points. With the detection level of 0.1%, the concordance between RQ-PCR and FCM was 90% in the 726 paired samples analyzed. At day 29, the correlation between the methods was greater with MRD levels >0.1% (rs=0.7, p<0.001) than below (rs=0.2, p=0.024). MRD levels higher than 0.1% at day 29 was a significant predictor of higher risk of having a bone marrow relapse. This was true both for BCP ALL and T-ALL analysed with either FCM or RQ-PCR, although RQ-PCR was a better discriminator than FCM in T-ALL. However, using the NOPHO ALL 2000 protocol, our data indicate that a higher cut-off value (0.2%) should be applied in BCP ALL when using RQ-PCR as MRD method. In contrast, MRD levels ≥ 0.1%, analysed with either method late during induction therapy, was not a predictor of isolated extramedullary relapse. We therefore conclude that MRD assessment by RQ-PCR based IG/TCR rearrangement and multicolour FCM monitoring can be used as a clinical tool if the aim is to find childhood ALL cases with increased risk of having bone marrow relapses.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Cell- och molekylärbiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Cell and Molecular Biology (hsv//eng)

Nyckelord

minimal residual disease
childhood acute lymphoblastic leukemia
flow cytometry
RQ-PCR
rearranged IG/TCR genes
Pathology
Patologi
Pathology
Patologi

Publikations- och innehållstyp

vet (ämneskategori)
ovr (ämneskategori)

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy